New Reference Materials Sourced to Meet the Needs of the World's Leading Toxicologists
News Oct 07, 2008
The recent meeting of the International Association of Forensic Toxicologists (TIAFT) highlighted a number of materials required for use as reference compounds and internal standards in applications such as testing for evidence of exposure to alcohol and drugs in substrates including blood, urine and hair. LGC Standards is pleased to announce that many of these new materials have now been sourced and are included in our recently revised and relaunched catalogue "Reference Materials for Clinical, Forensic and Sports Drugs Applications".
A particular example of an area of increasing interest to analysts is plant-derived chemicals which have toxic or psychoactive effects, or which can be used as precursors for controlled drugs. Here too, LGC Standards has been able to source a range of reference materials, such as kava alkaloids and Salvinorin A (the active ingredient of Salvia divinorum), and these phytochemical reference materials have also been included as a new chapter of the catalogue.
These and many other new reference standards, including deuterated materials, glucuronides and other metabolites, are now available to laboratories carrying out analysis for drugs of abuse, therapeutic drugs and sports doping agents, from LGC Standards offices throughout Europe.
The chapter with reference standards for clinical analysis is based on the Joint Committee for the Traceability in Laboratory Medicine (JCTLM) database. Drugs, enzymes, proteins and therapeutic drugs in blood, serum, urine and hair have been sourced from all over the world.
LGC Standards simplifies the sourcing of reference standards and can deal with the complex issue of legal requirements in relation to international trade of controlled substances. In addition, expert advice and assistance is available to source of substances that are not currently included in the catalogue.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
New Speakers from Roche and Imperial College London Announced for SMi’s ADMET EventNews
SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.READ MORE